Since our previous newsletter in March, the world suddenly and abruptly changed for all of us, due to COVID-19. Overnight, offices were closed, and isolation and face-to-face contact restrictions were imposed. The impact on research was immediate and dramatic, with all research endeavours (other than COVID-19) put on hold to ensure the safety and well-being Read more
News
ADNeT Director invited to join Davos Alzheimer’s Collaboration
Professor Chris Rowe has been invited to be part of the Davos Alzheimer’s Collaborative Global Clinical Trials Working Group in recognition of the success of ADNeT’s national clinical trial screening initiative as well as other activities designed to facilitate a national network of Dementia Clinical Trial sites in collaboration with Dementia Trials Australia. The Davos Read more
Dementia Registry gathers momentum
Despite delays due to the coronavirus pandemic, the roll-out of the ADNeT Dementia Clinical Quality Registry is gathering momentum. As with other clinical quality registries, the purpose of the ADNeT Clinical Registry is to become an effective tool for quality improvement in the diagnosis and care of dementia in Australia by identifying variations in clinical Read more
Can the quality of dementia care be measured?
ADNeT Registry Academic Lead Prof Susannah Ahern has led a Delphi study to develop clinical quality indicators (CQI) to measure the quality of care for dementia and mild cognitive impairment. The study – published online in the Journal of Alzheimer’s Disease[1] – assessed 33 indicators and confirmed a final set of 18. Seven of these quality Read more
Resources for Memory Clinics
ADNeT’s Memory Clinics Initiative has identified resources that may assist you in using telehealth and in the management of your Memory Clinic during this COVID-19 time. New guidelines for the administration of the Addenbrooke’s Cognitive Examination (ACE-III) via telehealth protocol have been developed. Instructions for the clinician and instructions for the carer who can support the Read more
ADNeT neuropsychology norming tool. A time-saver for neuropsychologists!
ADNeT-Memory Clinics is currently developing an electronic neuropsychology assessment tool with automated norm data comparison. The tool allows the clinician to produce a report that provides an overview of the client’s overall performance profile. We hope that this tool will save the neuropsychologists the time usually required to conduct a manual norm data comparison and Read more
First national Memory Clinics list
ADNeT-Memory Clinics is currently developing the first national list of Memory Clinics. ADNeT-Memory Clinics is aiming to build a postcode search tool that will help primary care clinicians and people with cognitive decline as well as their carers to locate specialised assessment services in their area. If you offer a specialised assessment service for the Read more
Register your interest for our peer support program!
ADNeT-Memory Clinics is setting-up a peer-support program (e.g., webinars on specific topics) and is currently obtaining expressions of interest from Memory Clinics clinicians. If you would be interested to participate in the peer-support program, please send an email to adnet.mc@unsw.edu.au to register your interest. Please let us know if you would like to Share your Read more
Cost-free dementia screening
ADNeT has recently received ethics approval to commence dementia screening at Macquarie University in Sydney and at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide. These two sites will be added soon to the screening sites operating in Melbourne and Perth. Clinicians, GPs as well as private and public memory clinics are Read more
Eisai Clarity clinical trial begins recruiting
The work of our Screening and Trials initiative has immediate benefits to people with dementia and Alzheimer’s disease by attracting to Australia major clinical trials and providing patients with access to novel therapies. ADNeT’s development of screening sites around the country and a database of pre-qualified suitable trial participants was central to bringing the Eisai Read more